臨床試驗

Optimizing Y90 Therapy for Radiation Lobectomy

NCT：NCT04390724 · ACTIVE_NOT_RECRUITING

NCT IDNCT04390724

狀態ACTIVE_NOT_RECRUITING

開始日期2020-07-17

完成時間2026-11-27

SponsorNorthwestern University (OTHER)

First posted2020-05-15

Last updated2026-09-16

簡要摘要

HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。